- Home
- IMAB vs HYPR Comparison
IMAB vs HYPR Comparison
Compare IMAB & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- HYPR
- Stock Information
- Founded
- IMAB 2014
- HYPR 2014
- Country
- IMAB United States
- HYPR United States
- Employees
- IMAB N/A
- HYPR 131
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- IMAB Health Care
- HYPR Health Care
- Exchange
- IMAB Nasdaq
- HYPR Nasdaq
- Market Cap
- IMAB 83.8M
- HYPR 68.6M
- IPO Year
- IMAB 2020
- HYPR N/A
- Fundamental
- Price
- IMAB $0.94
- HYPR $0.93
- Analyst Decision
- IMAB Strong Buy
- HYPR Hold
- Analyst Count
- IMAB 3
- HYPR 1
- Target Price
- IMAB $8.00
- HYPR $1.60
- AVG Volume (30 Days)
- IMAB 288.7K
- HYPR 103.3K
- Earning Date
- IMAB 08-28-2024
- HYPR 11-12-2024
- Dividend Yield
- IMAB N/A
- HYPR N/A
- EPS Growth
- IMAB N/A
- HYPR N/A
- EPS
- IMAB N/A
- HYPR N/A
- Revenue
- IMAB $3,313,984.00
- HYPR $13,255,000.00
- Revenue This Year
- IMAB N/A
- HYPR $31.75
- Revenue Next Year
- IMAB N/A
- HYPR $29.82
- P/E Ratio
- IMAB N/A
- HYPR N/A
- Revenue Growth
- IMAB N/A
- HYPR 35.67
- 52 Week Low
- IMAB $0.90
- HYPR $0.76
- 52 Week High
- IMAB $2.54
- HYPR $1.39
- Technical
- Relative Strength Index (RSI)
- IMAB 38.29
- HYPR 40.78
- Support Level
- IMAB $0.91
- HYPR $0.96
- Resistance Level
- IMAB $1.11
- HYPR $1.03
- Average True Range (ATR)
- IMAB 0.07
- HYPR 0.04
- MACD
- IMAB -0.00
- HYPR -0.01
- Stochastic Oscillator
- IMAB 13.01
- HYPR 5.09
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.